• DVM360_Conference_Charlotte,NC_banner
  • ACVCACVC
  • DVM 360
  • Fetch DVM 360Fetch DVM 360
DVM 360
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care
By Role
AssociatesOwnersPractice ManagerStudentsTechnicians
Subscriptions
dvm360 Newsletterdvm360 Magazine
News
All News
Association
Breaking News
Education
Equine
FDA
Law & Ethics
Market Trends
Medical
Politics
Products
Recalls
Regulatory
Media
dvm360 LIVE!™
Expert Interviews
The Vet Blast Podcast
Medical World News
Pet Connections
The Dilemma Live
Vet Perspectives™
Weekly Newscast
dvm360 Insights™
Publications
All Publications
dvm360
Firstline
Supplements
Vetted
Clinical
All Clinical
Anesthesia
Animal Welfare
Behavior
Cardiology
CBD in Pets
Dentistry
Dermatology
Diabetes
Emergency & Critical Care
Endocrinology
Equine Medicine
Exotic Animal Medicine
Feline Medicine
Gastroenterology
Imaging
Infectious Diseases
Integrative Medicine
Nutrition
Oncology
Ophthalmology
Orthopedics
Pain Management
Parasitology
Surgery
Toxicology
Urology & Nephrology
Virtual Care
Business
All Business
Business & Personal Finance
Hospital Design
Personnel Management
Practice Finances
Practice Operations
Wellbeing & Lifestyle
Continuing Education
Conferences
Conference Listing
Conference Proceedings
Upcoming dvm360 Conferences
Resources
CBD in Pets
CE Requirements by State
Contests
Partners
Spotlight Series
Team Meeting in a Box
Toolkit
Top Recommended Veterinary Products
Vet to Vet
Veterinary Heroes
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us

© 2023 MJH Life Sciences and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Advertisement
By Role
  • Associates
  • Owners
  • Practice Manager
  • Students
  • Technicians
Subscriptions
  • dvm360 Newsletter
  • dvm360 Magazine
  • Contact Us
  • Fetch DVM360 Conference
  • Terms and Conditions
  • Privacy
  • Do Not Sell My Information
  • About Us
  • MJHLS Brand Logo

© 2023 MJH Life Sciences™ and dvm360 | Veterinary News, Veterinarian Insights, Medicine, Pet Care. All rights reserved.

Just Ask the Expert: Are intact dogs less likely to get cancer?

June 1, 2013
Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)

Dr. Timothy Fan discusses whether this should be a consideration before performing routine spays and castrations.

Dr. Fan welcome oncology questions from veterinarians and veterinary technicians.

Click here to submit your question, or send an e-mail to vm@advanstar.com with the subject line "Oncology questions."

Q. I've heard about studies linking neutered dogs with an increased cancer risk. Should I take this into consideration before performing routine spays and castrations?

A. The epidemiologic findings in a recent study provide indirect and foundational evidence for the participation of gonadal status in susceptibility to or protection from various categorical causes of death in companion dogs.1 Based on the retrospective analysis of a very large cohort of female and male dogs, which were either gonadally sterilized (neutered) or intact, the findings of the study indicate that gonadal sterilization not only significantly impacts when companion dogs might die, but also provides novel information pertaining to why individuals die.

Dr. Timothy M. Fan

Advertisement

The study's specifics

Specifically, gonadal sterilization significantly increased life expectancy in both male and female dogs by 13.8% and 26.8%, respectively, in comparison to sexually intact individuals. Importantly, the study findings identified a substantial effect of gonadal sterilization on the cause of death, with sterilization of dogs being significantly protective for fatality associated with various categorical pathologic processes including infectious, traumatic, vascular, and degenerative disease processes.

In contrast, sterilized dogs were significantly more likely to experience fatality associated with select neoplastic and immune-mediated processes. The identified association between increased fatalities of sterilized dogs from either neoplastic or immune-mediated diseases has the potential to direct future hypothesis-driven experiments that specifically address the participatory roles of chronic gonadal hormone exposure on tumorigenesis and immune surveillance.

In the context of cancer, sterilized dogs had a significantly increased risk of death, independent of age, associated with transitional cell carcinoma, osteosarcoma, lymphoma, and mast cell tumors; however, the increased death risk from cancer was not preserved across all tumor histologies, as sterilization status did not significantly influence the incidence of mortality in dogs with other common cancers such as prostate carcinoma, squamous cell carcinoma, and melanoma.

More research needed

Based on these initial epidemiologic study observations, prospective investigations addressing the putative and mechanistic roles of chronic gonadal hormone exposure and specific cancer-related death risks are well-justified. However, at this point before additional hypothesis-driven experiments can be conducted, it would be premature and imprudent to recommend the avoidance of elective gonadal sterilization because of concerns of increased death risk from cancer in companion dogs. Future rigorous and definitive cause-and-effect scientific studies are required before changes in sterilization practices should be considered.

Timothy M. Fan, DVM, PhD, DACVIM (internal medicine, oncology)

Department of Veterinary Clinical Medicine

College of Veterinary Medicine

University of Illinois

Urbana, Ill.

REFERENCE

1. Hoffman JM, Creevy KE, Promislow DE. Reproductive capability is associated with lifespan and cause of death in companion dogs. PLoS One 2013;8(4):e61082.

Related Content:

Oncology
New clinical foods launched to support cats and dogs with cancer
New clinical foods launched to support cats and dogs with cancer
Study reveals OncoK9 liquid biopsy test can enhance cancer monitoring in canines
Study reveals OncoK9 liquid biopsy test can enhance cancer monitoring in canines
Morris Animal Foundation funds new study to test efficacy of immunotherapy for canine osteosarcoma
Morris Animal Foundation funds new study to test efficacy of immunotherapy for canine osteosarcoma

Advertisement

Latest News

Comparing treatments for restoring the skin barrier in atopic dogs

Increasing efficiency and productivity in uncertain times

AAVMC awards almost $100,000 in diversity scholarships

News wrap-up: This week’s headlines, plus Maryland Zoo welcomes baby addra gazelle

View More Latest News
Advertisement